E-ISSN 2534-9821
 
2023, Vol: 7, Issue: 12
7 / 12Current Issue Online FirstArchiveAims and ScopeAbstracting & IndexingMost Accessed ArticlesMost Downloaded ArticlesMost Cited Articles
Required files to be uploaded

Copyright Transfer Form

Case Report
Online Published: 23 Mar 2019
 


Discrepancy between Clinical Manifestations and Histopathological Features in Borderline Borderline Leprosy

Faridha Ilyas.


Abstract
Leprosy is a chronic and progressive granulomatous disease that primarily affects the skin and peripheral nervous system caused by Mycobacterium leprae. If left unrecognized, infection can cause permanent nerve damage and disability. The mid-borderline type is the most unstable type, where clinical presentation depends on the patient's immune response and may result in a broad spectrum of symptoms. ROM (rifampicin, ofloxacin, minocycline) is second-line therapy for leprosy recommended by WHO for patients who have contraindications or reject MDT administration.
A case of a 49-year-old male patient was reported with ulcer on the right hand, peeled skin on both hands, legs, accompanied with erythematous nodules and plaque, and hyperpigmented macules almost all over body. Skin all over body were painful and followed with fever. Clinical manifestation is mimicking borderline lepromatous and severe leprosy reaction, but histopathology result support Borderline borderline leprosy. The ptient was treated with Rifampisin, Ofloxacin, Minoksiklin (ROM) and Prednison, which resulted in significant clinical improvement

Key words: Borderline borderline, Leprosy, ROM


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Faridha Ilyas
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Faridha Ilyas|. Discrepancy between Clinical Manifestations and Histopathological Features in Borderline Borderline Leprosy. Int J Med Rev Case Rep. 2019; 3(5): 286-289. doi:10.5455/IJMRCR.borderline-leprosy-clinical-features

Web Style

Faridha Ilyas|. Discrepancy between Clinical Manifestations and Histopathological Features in Borderline Borderline Leprosy. https://www.mdpub.net/?mno=34368 [Access: April 02, 2025]. doi:10.5455/IJMRCR.borderline-leprosy-clinical-features

AMA (American Medical Association) Style

Faridha Ilyas|. Discrepancy between Clinical Manifestations and Histopathological Features in Borderline Borderline Leprosy. Int J Med Rev Case Rep. 2019; 3(5): 286-289. doi:10.5455/IJMRCR.borderline-leprosy-clinical-features


Vancouver/ICMJE Style

Faridha Ilyas|. Discrepancy between Clinical Manifestations and Histopathological Features in Borderline Borderline Leprosy. Int J Med Rev Case Rep. (2019), [cited April 02, 2025]; 3(5): 286-289. doi:10.5455/IJMRCR.borderline-leprosy-clinical-features


Harvard Style

Faridha Ilyas| (2019) Discrepancy between Clinical Manifestations and Histopathological Features in Borderline Borderline Leprosy. Int J Med Rev Case Rep, 3 (5), 286-289. doi:10.5455/IJMRCR.borderline-leprosy-clinical-features


Turabian Style

Faridha Ilyas|. 2019. Discrepancy between Clinical Manifestations and Histopathological Features in Borderline Borderline Leprosy. International Journal of Medical Reviews and Case Reports, 3 (5), 286-289. doi:10.5455/IJMRCR.borderline-leprosy-clinical-features


Chicago Style

Faridha Ilyas|. "Discrepancy between Clinical Manifestations and Histopathological Features in Borderline Borderline Leprosy." International Journal of Medical Reviews and Case Reports 3 (2019), 286-289. doi:10.5455/IJMRCR.borderline-leprosy-clinical-features


MLA (The Modern Language Association) Style

Faridha Ilyas|. "Discrepancy between Clinical Manifestations and Histopathological Features in Borderline Borderline Leprosy." International Journal of Medical Reviews and Case Reports 3.5 (2019), 286-289. Print. doi:10.5455/IJMRCR.borderline-leprosy-clinical-features


APA (American Psychological Association) Style

Faridha Ilyas| (2019) Discrepancy between Clinical Manifestations and Histopathological Features in Borderline Borderline Leprosy. International Journal of Medical Reviews and Case Reports, 3 (5), 286-289. doi:10.5455/IJMRCR.borderline-leprosy-clinical-features


Author LoginReviewer LoginAbout PublisherEditorial PoliciesEditorial Review PolicyPeer Review PolicyEditorial & Peer Review ProcessAuthor's Rights and ObligationsPublication Ethics and Publication Malpractice StatementConflict of Interest PolicyPlagiarism PolicyProtection of Research Participants (Statement On Human And Animal Rights)Privacy PolicyCorrections, Retractions & Expressions of ConcernSelf-Archiving PoliciesDigital Archiving & Preservation PoliciesStatement of Informed ConsentAdvertising PolicyTerms of UseLicense InformationCopyright Information

About International Journal of Medical Reviews and Case Reports

International Journal of Medical Reviews and Case Reports  (Int J Med Rev Case Rep)ISSN: 2534-9821The International Journal of Medical Reviews and Ca ... Read more.



For best results, please use Internet Explorer or Google Chrome.

Contact Information


Any correspondence, queries or additional requests for information on the manuscript submission process should be sent to the International Journal of Medical Reviews and Case Reports editorial office as follows:

Bulgarian Association of Young Surgeons (BAYS);

National Center of Public Health and Analyses (NCPHA), floor 2, office № 31,  Sofia 1431, Bulgaria.

inkov@journalmedica.com

Financial department is managed by International Sci Ink Press. 

It is a company registered in Bulgaria with registered no. 205414288 and registered address at 57 Antim I str., Vazrazhdane, Sofia, 1303, Bulgaria.

Tel: +359883427500